Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer

NCT01075113 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: sorafenib tosylate
DRUG: vorinostat

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]